Literature DB >> 18651332

Neuroendoscopic third ventriculostomy in the management of noncommunicating hydrocephalus secondary to giant basilar artery bifurcation aneurysm - case report and review of literature.

Krzysztof Stachura1, Witold Libionka, Marek Moskała.   

Abstract

Recently neuroendoscopic third ventriculostomy has become a well-established procedure for the treatment of noncommunicating hydrocephalus. However, morphological changes of the third ventricular floor can make endoscopic fenestration technically difficult, and increase the risk of injury to the basilar artery and perforators. The risk is especially high in patients with basilar artery bifurcation aneurysms, in whom aneurysm exclusion should precede treatment of hydrocephalus. If definitive aneurysm treatment is impossible or hazardous, endoscopic septostomy or shunting may be beneficial. However, reduction of intracranial hypertension may induce aneurysmal growth and rupture. We report upon a case of obstructive hydrocephalus produced by a non-ruptured partially thrombosed giant basilar artery bifurcation aneurysm, in which definitive treatment was considered impossible, successfully treated with neuroendoscopic third ventriculostomy. To the authors' knowledge this is the first reported case of its kind. The authors conclude that in similar cases neuroendoscopic ventriculostomy is worth trying if anatomical landmarks are identifiable.

Entities:  

Mesh:

Year:  2008        PMID: 18651332

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  2 in total

1.  Endoscopic third ventriculostomy - effectiveness of the procedure for obstructive hydrocephalus with different etiology in adults.

Authors:  Krzysztof Stachura; Ewelina Grzywna; Borys M Kwinta; Marek M Moskała
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2014-10-16       Impact factor: 1.195

2.  Endoscopic third ventriculostomy in treatment of hydrocephalus.

Authors:  Paweł Sokal; Marcin Birski; Marcin Rusinek; Darek Paczkowski; Piotr Zieliński; Aleksandra Harat
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2012-09-29       Impact factor: 1.195

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.